
January 2024
Calibre Scientific acquires Labtech, a UK based provider of life science instruments, products and services
Calibre Scientific is pleased to announce the acquisition of Labtech International Ltd (“Labtech” or the “Company”), a UK based provider of life science instruments, products and services to customers in the biotechnology, diagnostics, education, environmental and pharmaceutical sectors across the UK, and Ireland. This strategic acquisition reinforces Calibre Scientific's commitment to expanding its product and service offering in the British Isles.
Labtech is a leading life science and microscopy supply and service company in the UK and Ireland with a diversified instrument portfolio across the molecular biology, cell biology, microbiology, light microscopy and electron microscopy categories, as well as associated consumables and reagents. In addition, to supplying high-quality products and consumables, Labtech also provides a variety of support services to its customers including repair, calibration, validation and maintenance.
With this acquisition, Calibre Scientific broadens its analytical instrument offering whilst strengthening its presence and service capabilities across the British Isles. "Labtech’s product offering is highly complementary to Calibre Scientific’s existing life science equipment portfolio, opening up new commercial possibilities through partnership and collaboration,” said Ben Travis, Chief Executive Officer of Calibre Scientific. “This acquisition reaffirms our commitment to delivering an integrated offering of world-class laboratory instrumentation and services, thereby delivering a differentiated value proposition to our customers globally.”
“We are very proud of the reputation Labtech has built over its 30-year history,” said Dr. Brian Page, Director of Labtech. “Our diverse laboratory instrumentation portfolio and technical service capabilities will prosper even more under the ownership of Calibre Scientific, where its breadth of resources will further propel Labtech to its next stage of growth.”

